Treatment for Pancreatitis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Pancreatitis+1 More
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help to determine if a urine test can accurately diagnose pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).

Eligible Conditions
  • Pancreatitis
  • Post ERCP Acute Pancreatitis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Urine dipstick testing assessed 2-3 hours following ERCP, for post ERCP pancreaitits.

Hour 3
Pancreatitis

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

1825 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: urine dipstick testing assessed 2-3 hours following ercp, for post ercp pancreaitits.

Who is running the clinical trial?

Indiana UniversityLead Sponsor
868 Previous Clinical Trials
747,093 Total Patients Enrolled
11 Trials studying Pancreatitis
3,032 Patients Enrolled for Pancreatitis
Jeffrey Easler, MD5.01 ReviewsPrincipal Investigator - Indiana University
Indiana University
1 Previous Clinical Trials

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 2nd, 2021

Last Reviewed: October 17th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.